Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 455 M481 M535 M493 M 1.96 B Research & development ———— — Operating income 16 M-12 M46 M-27 M 23 M Non-Operating Income, Total 6 M-3 M04 M 7 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 5 M-3 M00 2 M Unusual income/expense 1 M004 M 5 M Pretax income 40 M2 M55 M10 M 107 M Equity in earnings ———— — Taxes -16 M36 M-2 M9 M 27 M Non-controlling/minority interest 0001 M 1 M After tax other income/expense -1 M-2 M-23 M2 M -24 M Net income before discontinued operations 56 M-34 M57 M0 79 M Discontinued operations -3 M6 M59 M-4 M 58 M Net income 53 M-28 M116 M-4 M 137 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 53 M-28 M116 M-4 M 137 M Basic earnings per share (Basic EPS) 0.44-0.220.96-0.04 1.14 Diluted earnings per share (Diluted EPS) 0.44-0.220.96-0.04 1.14 Average basic shares outstanding 118.8 M119.79 M119.85 M119.31 M — Diluted shares outstanding 119.11 M119.79 M120.6 M119.85 M — EBITDA 46 M18 M76 M25 M 165 M EBIT 16 M-12 M46 M-27 M 23 M Cost of revenue 295 M334 M402 M280 M 1.31 B Other cost of goods sold 295 M334 M402 M280 M 1.31 B Depreciation & amortization (cash flow) 30 M30 M30 M52 M 142 M